Compound Detail
CHEMBL2022379
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1
Basic Information
| ChEMBL ID | CHEMBL2022379 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RIQJIFBZCJKJLX-UHFFFAOYSA-N |
7
Targets
7
Activities
2
Assay Types
0
PK Parameters
7
Publications
0
Known Names
Molecular Properties
542.7
MW (Da)
4.37
ALogP
11
HBA
2
HBD
118.2
PSA (Ų)
0.30
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 7.92
EC50 1 meas. best 7.08
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Aurora kinase A CHEMBL4722 | IC50 | 7.92 | 7.92 | 12.0 | 1 |
| Aurora kinase B CHEMBL2185 | EC50 | 7.08 | 7.08 | 83.0 | 1 |
| Serine/threonine-protein kinase Chk1 CHEMBL4630 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 6.97 | 6.97 | 108.0 | 1 |
| Tyrosine-protein kinase Lck CHEMBL258 | IC50 | 6.14 | 6.14 | 731.0 | 1 |
| Ribosomal protein S6 kinase alpha-3 CHEMBL2345 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Interleukin-1 receptor-associated kinase 4 CHEMBL3778 | IC50 | 5.94 | 5.94 | 1142.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Aurora kinase A | IC50 | = | 12.0 | nM | 7.92 | Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluores... | 22503250 |
| Aurora kinase B | EC50 | = | 83.0 | nM | 7.08 | Inhibition of aurora B kinase in human HCT116 cells assessed as inhibition of hi... | 22503250 |
| Serine/threonine-protein kinase Chk1 | IC50 | = | 100.0 | nM | 7.0 | Inhibition of Chk1 | 22503250 |
| Vascular endothelial growth factor receptor 2 | IC50 | = | 108.0 | nM | 6.97 | Inhibition of VEGFR2 | 22503250 |
| Tyrosine-protein kinase Lck | IC50 | = | 731.0 | nM | 6.14 | Inhibition of LCK | 22503250 |
| Ribosomal protein S6 kinase alpha-3 | IC50 | = | 1100.0 | nM | 5.96 | Inhibition of RSK2 | 22503250 |
| Interleukin-1 receptor-associated kinase 4 | IC50 | = | 1142.0 | nM | 5.94 | Inhibition of IRAK4 | 22503250 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22503250 | 10.1016/j.bmcl.2012.03.051 | Aurora kinase B | 2 |
| 22503250 | 10.1016/j.bmcl.2012.03.051 | Aurora kinase A | 1 |
| 22503250 | 10.1016/j.bmcl.2012.03.051 | Vascular endothelial growth factor receptor 2 | 1 |
| 22503250 | 10.1016/j.bmcl.2012.03.051 | Tyrosine-protein kinase Lck | 1 |
| 22503250 | 10.1016/j.bmcl.2012.03.051 | Serine/threonine-protein kinase Chk1 | 1 |
| 22503250 | 10.1016/j.bmcl.2012.03.051 | Interleukin-1 receptor-associated kinase 4 | 1 |
| 22503250 | 10.1016/j.bmcl.2012.03.051 | Ribosomal protein S6 kinase alpha-3 | 1 |
Data from ChEMBL 36 via Core Engine